We are live on ! Find out more
ICM

Invenomic Capital Management Portfolio holdings

AUM $2.18B
1-Year Est. Return 0.03%
This Fund
S&P 500
This Quarter Est. Return
+3.41%
1 Year Est. Return
+0.03%
3 Year Est. Return
-6.37%
5 Year Est. Return
-25.27%
10 Year Est. Return
–
AUM
$1.76B
AUM Growth
-$218M
Cap. Flow
-$265M
Cap. Flow %
-15.02%
Top 10 Hldgs %
22.75%
Holding
203
New
31
Increased
55
Reduced
62
Closed
55

Top Buys

Rank Stock Value
1
RNG icon
RingCentral
RNG
+$36.8M
2
ACHC icon
Acadia Healthcare
ACHC
+$30.7M
3
BILL icon
BILL Holdings
BILL
+$20.8M
4
OMC icon
Omnicom Group
OMC
+$15.9M
5
EQX icon
Equinox Gold
EQX
+$14.9M

Top Sells

Rank Stock Value
1
DNB
Dun & Bradstreet
DNB
+$33.6M
2
SLB icon
SLB Ltd
SLB
+$23.7M
3
MTCH icon
Match Group
MTCH
+$22.9M
4
MUR icon
Murphy Oil
MUR
+$19.4M
5
LYFT icon
Lyft
LYFT
+$18.8M

Sector Composition

Rank Sector Weight
1 Technology 25.6%
2 Consumer Discretionary 17.8%
3 Healthcare 16.38%
4 Industrials 9.22%
5 Materials 9.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ZM icon
201
Zoom
ZM
$30.6B
– –
-224,688
Closed -$16.6M
PENG
202
Penguin Solutions Inc
PENG
$2.99B
– –
-364,632
Closed -$6.33M
XYZ
203
Block Inc
XYZ
$47.5B
– –
-91,993
Closed -$5M
5 6 7 8
9

Similar funds

SIG
Senator Investment Group New York $2.18B AUM 58.56% 1-Year Est. Return
CAG
Csenge Advisory Group Clearwater, Florida $2.18B AUM 16.73% 1-Year Est. Return
ORCP
One Rock Capital Partners New York $2.19B AUM
ET
Entropy Technologies New York $2.17B AUM 21.46% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
MIAS
Mason Investment Advisory Services Reston, Virginia $2.17B AUM 28.39% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
IIP
Intermede Investment Partners London, United Kingdom $2.16B AUM 18.47% 1-Year Est. Return

Invenomic Capital Management's Q2 2025 Portfolio in Review

As of Q2 2025, Invenomic Capital Management held 203 positions worth $1.76B, down 11% from $1.98B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Invenomic Capital Management withdrew a net $265M in Q2 2025, closing 55 positions and reducing 62 holdings. Its most notable exit was Dun & Bradstreet, an estimated $33.6M position sold in full.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 22% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Invenomic Capital Management opened a new position in RingCentral worth $40.5M.

  • Invenomic Capital Management's largest Q2 2025 buy was RingCentral: 1,427,359 shares worth $40.5M.
  • Invenomic Capital Management added most to Acadia Healthcare in Q2 2025, an estimated $30.7M increase.
  • Invenomic Capital Management's biggest Q2 2025 reduction was Match Group, cutting an estimated $22.9M.
  • Invenomic Capital Management fully exited Dun & Bradstreet in Q2 2025, selling an estimated $33.6M.
  • Invenomic Capital Management's ten largest holdings make up 23% of its $1.76B portfolio in Q2 2025.
  • Invenomic Capital Management opened 31 new positions and closed 55 in Q2 2025.
  • Invenomic Capital Management's portfolio value fell 11% quarter-over-quarter to $1.76B.

Based on Invenomic Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.